Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, January 17, 2014 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/zqlcks/biochip_products) has announced the addition of the "2013 Report on the US Biochip Products and Services Market - Trends and Forecast to 2018" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The U.S. biochip product market held majority share of the total biochip market in 2011, at over 70%. However, the U.S. biochip services market will grow faster than the products market, due to increased opportunities of maintenance and technical support of microarray devices owing to growth in their numbers and obsolescence of older machines. The growth of this segment will also be spurred by the introduction of biochip consulting and subscription programs directed towards building long term relationships with customers.
Biochip services consist of contract research, consulting and technical support agreements. These also comprise of subscription programs that provide end-users with access to proprietary technologies, systems and processes. These services are directed towards building long term relationships with customers.
In the U.S. biochip products market, the microarray market is identified as the most attractive segment owing to the following factors:
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 U.S. Biochip Market, by Segments
5 U.S. Biochip Products Market, by Type
6 The U.S. Biochip Products and Services Market, by Application
7 Competitive Landscape
8 Company Profiles
For more information visit http://www.researchandmarkets.com/research/zqlcks/biochip_products
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.